The wide availability of PCR-based methods for the amplification of nucleic acids homologous to known viral genomes plus automated DNA sequencing have led to explosive growth of a new field, \'proxy\' virus isolation. Typically, genomic fragments are amplified and subjected to phylogenetic analysis showing that they are related to, but distinct from, known \'*bona fide*\' viruses. These \"new viruses\" are now commonly reported in the virological literature and are too numerous to cite here, two studies are given as typical examples \[[@B1],[@B2]\]. Although unintentional, these reports may, mislead the readership of scientific journals and the general press. Having no distinction between preliminary genome-based evidence and conclusive proof by biological isolation and characterization of a replication-competent virus blurs the meaning of new virus.

To distinguish presumptive viruses known primarily through genomic sequence fragments from *bona fide*viruses we propose the term **\'frag-virus\'**.

The \'frag-virus status\' may be intermediary between \'full\' recognition as a new virus, as occurred, for example, with hepatitis C virus and Kaposi sarcoma herpesvirus \[[@B3]-[@B6]\]. Frag-virus designation may also be a category for such virus that likely exists, but there is neither sufficient motivation nor resources to pursue its elevation from frag-virus limbo to *bona fide*virus status. At the same time the frag-virus status will be a \'career end-point\' for sequences belonging to non-infectious \'pseudo-viruses\' or those having their origins in artifact.

Whatever the \'fate\' of frag-viruses, this simple term is highly informative and may prove useful in preventing misconceptions about new viruses.
